Report overview
Anemia is a condition in which you don't have enough healthy red blood cells to carry adequate oxygen to the body's tissues.
This report contains market size and forecasts of Anemia Treatment Drugs in Global, including the following market information:
Global Anemia Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anemia Treatment Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Supplements Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anemia Treatment Drugs include Pfizer, Inc., Amgen, Inc., Hoffmann-La Roche Ltd., Merck Sharp & Dohme Corp., Novartis AG, Janssen Pharmaceutical, Bayer AG, AMAG Pharmaceuticals and GlaxoSmithKline plc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anemia Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anemia Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anemia Treatment Drugs Market Segment Percentages, by Type, 2021 (%)
Supplements
Antibiotics
Immunosuppressant
Bone Marrow Stimulants
Corticosteroids
Gene Therapy
Iron Chelating Agents
Global Anemia Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anemia Treatment Drugs Market Segment Percentages, by Application, 2021 (%)
Iron deficiency anemia
Thalassemia
Aplastic anemia
Hemolytic anemia
Sickle cell anemia
Pernicious anemia
Global Anemia Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anemia Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anemia Treatment Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anemia Treatment Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer, Inc.
Amgen, Inc.
Hoffmann-La Roche Ltd.
Merck Sharp & Dohme Corp.
Novartis AG
Janssen Pharmaceutical
Bayer AG
AMAG Pharmaceuticals
GlaxoSmithKline plc
Akebia Therapeutics
Vifor Pharma Management, Ltd.
FibroGen, Inc.
